Shots:

• MappBio collaborates with Aridis Pharmaceuticals to develop mAbs productivity enhanced versions of CHO cell lines utilizing Aridis’s APEX Technology
• CHO cell lines are developed from Chinese hamster ovary. The CHO cell line are developed by MappBio
• APEX technology is a mAb discovery platform that enables the screening and single cell cloning of antibody producing B-cells using microarrays and is built upon Aridis’ hybridoma-based technology platform- MabIgX allowing rapid fusion and production of mAbs directly from patients antibody-producing B-cells

Click here to read full press release/ article | Ref: Aridis Pharmaceuticals | Image: Twitter